BAY-1158061

N/A

Report date: 2026/05/26 20:00:28

Base Information

Drug NameBAY-1158061
Drug Alias NameBAY-1158061HMI-115
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionProlactin receptor antagonists
TargetsProlactin receptor
Therapy Area/IndicationsPainAlopeciaEndometriosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPolandAustralia +[4
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesBayer AG
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Inactive CompaniesN/A
Active IndicationsPainAlopeciaEndometriosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A